BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 21148812)

  • 21. Osteonecrosis in children with acute lymphoblastic leukemia.
    Kunstreich M; Kummer S; Laws HJ; Borkhardt A; Kuhlen M
    Haematologica; 2016 Nov; 101(11):1295-1305. PubMed ID: 27742768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemia.
    Finkelstein Y; Blonquist TM; Vijayanathan V; Stevenson KE; Neuberg DS; Silverman LB; Vrooman LM; Sallan SE; Cole PD
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27957785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetics of pleiotropic effects of dexamethasone.
    Ramsey LB; Pounds S; Cheng C; Cao X; Yang W; Smith C; Karol SE; Liu C; Panetta JC; Inaba H; Rubnitz JE; Metzger ML; Ribeiro RC; Sandlund JT; Jeha S; Pui CH; Evans WE; Relling MV
    Pharmacogenet Genomics; 2017 Aug; 27(8):294-302. PubMed ID: 28628558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of BCL2L11 polymorphism on osteonecrosis during treatment of childhood acute lymphoblastic leukemia.
    Plesa M; Gagné V; Glisovic S; Younan M; Sharif-Askari B; Laverdière C; Alos N; Leclerc JM; Sallan SE; Neuberg D; Kutok JL; Silverman LB; Sinnett D; Krajinovic M
    Pharmacogenomics J; 2019 Feb; 19(1):33-41. PubMed ID: 29282361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. British OsteoNEcrosis Study (BONES) protocol: a prospective cohort study to examine the natural history of osteonecrosis in older children, teenagers and young adults with acute lymphoblastic leukaemia and lymphoblastic lymphoma.
    Amin N; Kinsey S; Feltbower R; Kraft J; Whitehead E; Velangi M; James B
    BMJ Open; 2019 May; 9(5):e027204. PubMed ID: 31122988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia.
    Karol SE; Mattano LA; Yang W; Maloney KW; Smith C; Liu C; Ramsey LB; Fernandez CA; Chang TY; Neale G; Cheng C; Mardis E; Fulton R; Scheet P; San Lucas FA; Larsen EC; Loh ML; Raetz EA; Hunger SP; Devidas M; Relling MV
    Blood; 2016 Feb; 127(5):558-64. PubMed ID: 26590194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
    den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
    Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence, risk factors, and treatment outcome of symptomatic osteonecrosis in Taiwanese children with acute lymphoblastic leukemia: a retrospective cohort study of 245 patients in a single institution.
    Chen SH; Chang TY; Jaing TH; Lee MS; Wang CJ; Hung IJ; Yang CP
    Int J Hematol; 2015 Jul; 102(1):41-7. PubMed ID: 25840770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylenetetrahydrofolate reductase gene polymorphism and glucocorticoid intake in children with ALL and aseptic osteonecrosis.
    Bernbeck B; Mauz-Körholz C; Zotz RB; Göbel U
    Klin Padiatr; 2003; 215(6):327-31. PubMed ID: 14677097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Levien MG
    Clin Pediatr (Phila); 2002; 41(1):63-4. PubMed ID: 11866371
    [No Abstract]   [Full Text] [Related]  

  • 31. Osteonecrosis in pediatric patients with acute lymphoblastic leukemia.
    Murphy RG; Greenberg ML
    Cancer; 1990 Apr; 65(8):1717-21. PubMed ID: 2317754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteonecrosis of the Shoulders in Pediatric Patients Treated for Leukemia or Lymphoma: Single-Institutional Experience.
    Kaste SC; DeFeo BM; Neel MD; Weiss KS; Fernandez-Pineda I; Ness KK
    J Pediatr Orthop; 2019 Feb; 39(2):104-110. PubMed ID: 28452860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia.
    Kadan-Lottick NS; Brouwers P; Breiger D; Kaleita T; Dziura J; Liu H; Chen L; Nicoletti M; Stork L; Bostrom B; Neglia JP
    Blood; 2009 Aug; 114(9):1746-52. PubMed ID: 19546477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteonecrosis in children treated for acute lymphoblastic leukemia: a magnetic resonance imaging study after treatment.
    Düzovali O
    Med Pediatr Oncol; 1999 Feb; 32(2):154-5. PubMed ID: 9950209
    [No Abstract]   [Full Text] [Related]  

  • 35. Bone pain at leukemia diagnosis and other risk factors for symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
    Barzilai-Birenboim S; Yacobovich J; Zalcberg Y; Arad-Cohen N; Avrahami G; Gilad G; Litichever N; Izraeli S; Elitzur S
    Pediatr Blood Cancer; 2021 Aug; 68(8):e29033. PubMed ID: 33788395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia.
    te Winkel ML; Appel IM; Pieters R; van den Heuvel-Eibrink MM
    Haematologica; 2008 Oct; 93(10):1570-4. PubMed ID: 18698082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteonecrosis in children with acute lymphoblastic leukemia at initial diagnosis and prior to any chemotherapy.
    Krull K; Kunstreich M; Bronsema A; Bleckmann K; Classen CF; Erdlenbruch B; Jorch N; Kolb R; Leipold A; Moser O; Prokop A; Scheurlen W; Steinbach D; Klasen-Sansone J; Klee D; Escherich G; Moericke A; Schrappe M; Borkhardt A; Kuhlen M
    Leuk Lymphoma; 2019 Jan; 60(1):78-84. PubMed ID: 29718744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteonecrosis in children with acute lymphoblastic leukemia: A report from Children's Cancer Hospital Egypt (CCHE).
    Ali N; Gohar S; Zaky I; Elghoneimy A; Youssef S; Sameer G; Yassin D; Salem S; Magdi H; Sidhom I
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27440. PubMed ID: 30183135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia.
    Badhiwala JH; Nayiager T; Athale UH
    Pediatr Blood Cancer; 2015 Oct; 62(10):1851-4. PubMed ID: 25931304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
    Hyakuna N; Shimomura Y; Watanabe A; Taga T; Kikuta A; Matsushita T; Kogawa K; Kawakami C; Horikoshi Y; Iwai T; Okamoto Y; Tsurusawa M; Asami K;
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):22-9. PubMed ID: 24136019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.